Addressing and managing comorbidities

23 May 2023

By IFPA

IFPA Forum 2023 Asia

Optimal treatment of psoriatic disease and its comorbidities requires shifting to a people-centered, multidisciplinary, and health service model. Person-centered care is essential to improve the quality of life for people living with psoriatic disease.

ifpa-pso.com/global-actions/forum

Related content

tool Advocacy, IFPA Forum

Collaborative research for psoriatic disease

tool Advocacy, Comorbidities, IFPA Forum

Psoriatic disease and non-communicable diseases

tool Universal Health Coverage, Advocacy, Care and Treatment, IFPA Forum

Access to care and early detection of psoriatic disease

report Advocacy, Comorbidities, Living with Psoriatic Disease, Care and Treatment, Reports, IFPA Forum

IFPA Forum 2025 Briefing Book

Combined Shape
Combined Shape
Screenshot 2024 12 10 152634

Article Stigma, Care and Treatment

Recommendations for Health Care Professionals
Combined Shape
Combined Shape
Shape External link

Cost of treatment unbearable for patients: PA Ghana urges capture of psoriasis under NHIS